GWM
EBS icon

Geneos Wealth Management’s Emergent Biosolutions EBS Stock Holding History

Geneos Wealth Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-124
Closed -$3K – 2091
2017
Q1 		$3K Sell
124
-77
-38% -$2.34K ﹤0.01% 1800
2016
Q4 		$6K Hold
201
– – ﹤0.01% 1566
2016
Q3 		$6K Sell
201
-33
-14% -$959 ﹤0.01% 1504
2016
Q2 		$6K Sell
234
-220
-48% -$8.63K ﹤0.01% 1456
2016
Q1 		$16K Buy
+454
New +$16K ﹤0.01% 1151

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AAM
Aberdeen Asset Management Aberdeen, United Kingdom $30B AUM 22.46% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Geneos Wealth Management's EBS Position: Q2 2017 in Review

Geneos Wealth Management sold out of Emergent Biosolutions (EBS) in Q2 2017, closing a stake of 124 shares — an estimated $3K sold.

Geneos Wealth Management first reported a position in EBS in Q1 2016 and held it in 5 quarters. The position peaked at $16K in Q1 2016. 181 funds tracked by Wall St. Rank hold EBS as of Q2 2017.

  • Geneos Wealth Management reported no remaining Emergent Biosolutions position as of Q2 2017 after selling out during the quarter.
  • Geneos Wealth Management sold 124 Emergent Biosolutions shares in Q2 2017, an estimated $3K.
  • Geneos Wealth Management first reported a position in Emergent Biosolutions in Q1 2016 and held it in 5 quarters.
  • Geneos Wealth Management's Emergent Biosolutions position peaked at $16K in Q1 2016.
  • 181 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2017.

Based on Geneos Wealth Management's 13F filing for Q2 2017, filed 7 Sep 2021.